Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications

被引:14
作者
Ashrani, AA
Aysola, A
Al-Khatib, H
Nichols, WL
Key, NS
机构
[1] Univ Minnesota, Sch Med, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[3] St Cloud Hosp, St Cloud, MN USA
[4] Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Special Coagulat Lab, Rochester, MN 55905 USA
关键词
lupus anticoagulant; acquired factor X deficiency; bleeding disorder; bleeding diathesis; respiratory infection;
D O I
10.1046/j.1365-2141.2003.04325.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acquired factor X (FX) deficiency is rare, but has been reported in diverse disease states, including systemic amyloidosis and respiratory infections. FX deficiency associated with lupus anticoagulant (LA) and a bleeding diathesis has not been previously reported. We report two patients both of whom presented with a severe bleeding diathesis after a preceding respiratory infection due to isolated FX deficiency associated with a LA. The FX deficiency and LA were transient. We conclude that patients with LA may rarely present with severe acquired FX deficiency. This may be another mechanism whereby patients with antiphospholipid antibodies present with bleeding complications.
引用
收藏
页码:639 / 642
页数:4
相关论文
共 12 条
[1]  
Arnout J, 2001, THROMB HAEMOSTASIS, V86, P83
[2]   Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency [J].
Boggio, L ;
Green, D .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) :1074-1075
[3]   Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy [J].
Choufani, EB ;
Sanchorawala, V ;
Ernst, T ;
Quillen, K ;
Skinner, M ;
Wright, DG ;
Seldin, DC .
BLOOD, 2001, 97 (06) :1885-1887
[4]  
CURRIE MS, 1984, NEW YORK STATE J MED, V84, P572
[5]  
EDSON JR, 1984, BLOOD, V64, P807
[6]   Antiprothrombin antibodies: Detection and clinical significance in the antiphospholipid syndrome [J].
Galli, M ;
Barbui, T .
BLOOD, 1999, 93 (07) :2149-2157
[7]   Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII [J].
Jones, DW ;
Gallimore, MJ ;
Mackie, IJ ;
Harris, SL ;
Winter, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) :721-726
[8]   A UNIQUE CIRCULATING INHIBITOR WITH SPECIFICITY FOR COAGULATION FACTOR-X [J].
LANKIEWICZ, MW ;
BELL, WR .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (03) :343-346
[9]   Testing homology modeling on mutant proteins: Predicting structural and thermodynamic effects in the Ala98->Val mutants of T4 lysozyme [J].
Lee, C .
FOLDING & DESIGN, 1996, 1 (01) :1-12
[10]   A CASE OF ACQUIRED FACTOR-X DEFICIENCY WITH INVIVO AND INVITRO EVIDENCE OF INHIBITOR ACTIVITY DIRECTED AGAINST FACTOR-X [J].
MULHARE, PE ;
TRACY, PB ;
GOLDEN, EA ;
BRANDA, RF ;
BOVILL, EG .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (02) :196-200